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Abstract
Color vision impairment was examined in patients with type 2 diabetes mellitus ~DM2! without retinopathy. We
assessed the type and degree of distortions of individual color spaces. DM2 patients ~n  32!, and age-matched
controls ~n  20! were tested using the Farnsworth D-15 and the Lanthony D-15d tests. In addition, subsets of caps
from both tests were employed in a triadic procedure ~Bimler & Kirkland, 2004!. Matrices of inter-cap subjective
dissimilarities were estimated from each subject’s “odd-one-out” choices, and processed using non-metric
multidimensional scaling. Two-dimensional color spaces, individual and group ~DM2 patients; controls!, were
reconstructed, with the axes interpreted as the R0G and B0Y perceptual opponent systems. Compared to controls,
patient results were not significant for the D-15 and D-15d. In contrast, in the triadic procedure the residual
distances were significantly different compared to controls: right eye, P  0.021, and left eye, P  0.022. Color
space configurations for the DM2 patients were compressed along the B0Y and R0G dimensions. The present
findings agree with earlier studies demonstrating diffuse losses in early stages of DM2. The proposed method of
testing uses color spaces to represent discrimination and provides more differentiated quantitative diagnosis, which
may be interpreted as the perceptual color system affected. In addition, it enables the detection of very mild color
vision impairment that is not captured by the D-15d test. Along with fundoscopy, individual color spaces may serve
for monitoring early functional changes and thereby to support a treatment strategy.
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Introduction
Diabetes mellitus is accompanied by retinopathy, which may result
in visual dysfunction, including color vision losses ~Ismail &
Whitaker, 1998!. In patients with type 2 diabetes mellitus ~DM2!
who developed diabetic retinopathy ~DR!, losses in the B0Y
confusion axis ~tritan! have been reported and shown to increase
with severity of DR ~Barton et al., 2004; Fong et al., 1999; Ismail
& Whitaker, 1998; Bresnick et al., 1985!. Color vision impairment
may precede DR and emerge at early stages of DM2, before the
appearance of vascular alterations in the retina. At this stage,
predominantly tritan losses were found ~Ismail & Whitaker, 1998!,
but other authors reported diffuse losses as well ~Trick et al., 1988;
Ventura et al., 2003!.
In most of these studies color vision was examined with
arrangement tests, such as the Farnsworth-Munsell 100-hue test
~FM-100!, or with the anomaloscope, to estimate Rayleigh ~red-
green! and Moreland ~blue-green!matches ~e.g., Kurtenbach et al.,
2002!. The outcome of the arrangement tests enables one, in the
first place, to assess color vision loss ~i.e. whether blue-yellow
~B0Y! and0or red-green ~R0G! discrimination is impaired!. The
FM-100 also provides an error score, which measures the overall
loss of color discrimination. The anomaloscope matches give
separate results for the two perceptual systems ~B0Y and R0G!,
but the extrapolation from matching range to color impairment is
far from direct.
In this study we investigated color vision in patients with DM2
without DR, in an attempt to assess impairment of color discrim-
ination quantitatively, in terms of distortions of a color space. This
study belongs to a tradition of color research, in which subjects
assess the dissimilarities they perceive among color stimuli, as a
way of probing the forms of variation among those subjects ~Helm,
1964; Paramei et al., 1991; Shepard & Cooper, 1992!.
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A color space is a geometric representation of relations among
colors, where the distance between a pair of colors reflects their
perceptual difference ~Helm & Tucker, 1962!. As was first pointed
out by Farnsworth ~1943!, color abnormalities can be represented
as distortions of a normal color space. One parameter is interpreted
as the axis along which the color space is compressed ~the axis of
color confusion!. Another parameter is the extent of compression,
which distinguishes normal trichromats from color-vision defi-
cient; and among those, anomalous trichromats from dichromats.
The arrangement tests, including the widely used FM-100, D-15
~Farnsworth, 1943! and D-15d ~Lanthony, 1978! tests, are based
on this concept. The two parameters can be assessed qualitatively
by visual inspection of individual data plotted on a suitable dia-
gram, and quantitatively by a vector-moment analysis ~Vingrys &
King-Smith, 1988!.
Color spaces for individual observers can be reconstructed
from estimates of color dissimilarity among the test caps, by
applying multidimensional scaling ~MDS! ~Kruskal & Wish, 1978!.
Group ~consensus! color spaces can also be computed. In a sub-
sequent step, color vision impairment can be considered as a
distortion of the color space obtained from controls. The distortion
is characterized by both the axes ~interpreted as R0G and B0Y!
and the degree of compression of each axis. This paradigm has
been used to model color discrimination for various types of
congenital color vision deficiencies ~Helm, 1964; Paramei et al.,
1991; Shepard & Cooper, 1992; Bimler et al., 2000!. Helm ~1964!
used a triadic procedure to elicit dissimilarities among a D-15-like
array of 10 Munsell chips, and distinguished color-deficient from
normal observers by analyzing the data with MDS.
The present study is an attempt to represent acquired color
vision impairment in DM2 patients in terms of distortions of a
color space. Estimates of color dissimilarity were obtained among
D-15 and D-15d test caps, using a triadic procedure, from DM2
patients and control subjects. Previous applications of this non-
traditional procedure have found it to be sensitive to quite subtle
differences in color space ~e.g. comparing smokers and non-
smokers; Bimler & Kirkland, 2004!. Thus the approach was ex-
pected to be capable of detection of subtle disease manifestations.
Materials and methods
Subjects
Thirty-two DM2 patients ~18 males!, aged from 30 to 76 years
~mean  50.5, SD  10.7!, with disease duration from 0.5 to 27
years ~mean  9, SD  8.6!, were examined. The absence of
retinopathy was verified in fundoscopy ~in 100% of the eyes! and
by fundus photography and fluorescein angiography ~62% of the
eyes were examined; 100% of these lacked any sign of retinopa-
thy!. Twenty age-matched observers ~15 males!, aged from 35 to
80 years ~mean  51.17, SD  11.5!, served as controls.
Inclusion criteria for both groups were: best corrected Snellen
visual acuity ~VA! 20030 or better; absence of retinopathy and
known ophthalmologic pathologies; absence of posterior subcap-
sular cataract, and maximum of grade 1 for cortical opacity ~C1!,
nuclear color ~NC1!, and nuclear opalescence ~NO1! following
chart for lens opacity classification system III ~LOCS III!.
Stimuli
For initial diagnosis, the D-15 and D-15d tests were used, each
consisting of 16 color caps forming a color circle. In Munsell
denotation, the D-15 caps have Value  5 and Chroma  4
~Farnsworth, 1943!; the D-15d caps have the same hue but are
lighter, with Value 8, and less saturated, Chroma 2 ~Lanthony,
1978!. The D-15 test was used for screening congenital color
vision deficiencies, whereas the more sensitive D-15d test was
employed to examine acquired color vision loss caused by diabetes.
For the experimental triadic procedure, a composite assortment
of 15 caps was created by excluding the reference caps from the
D-15 and the D-15d, and replacing the D-15 caps No. 3, 6, 9, 12,
and 15 with their counterparts from the D-15d.
Procedure
D-15 and D-15d tests
The D-15 and D-15d tests were both used in the traditional way:
starting with the reference cap, the subject arranged the stimuli in
a color sequence, where each cap was followed by the cap most
similar to it. This procedure was performed at the beginning of the
session.
Triadic procedure
Next, the 15-cap composite assortment was shuffled into five
randomized groups of three. The subject viewed each of these
triads separately and chose the most dissimilar cap of each triad
~‘the odd-one-out’!. No time limit was set. This procedure was
repeated 14 times, eliciting 70 triad judgments ~Bimler & Kirk-
land, 2004!.
Illumination of 500 lux was provided by two fluorescent lamps
~Sylvania Octron FO32W, with Coordinated Color Temperature
6500 K, Color Rendering Index  75!.
Both procedures were administered monocularly, in a randomly
chosen order, in the two eyes for DM2 patients and in one eye for
controls.
Analysis
D-15 and D-15d tests
Outcomes of the D-15 and D-15d tests were individual dia-
grams and a Total Color Distance Score ~TCDS! ~D-15: Bowman,
1982; D-15d: Geller, 2001!. Higher TCDS score values indicate
deviation from the errorless cap arrangement.
Triadic procedure
The following algorithm was used to estimate the dissimilarity
D~i, j ! between the i-th and j-th caps. The caps are represented as
points v~i !, where all pairs of points are initially equally distant.
This involves a 15-dimensional space, where each v~i ! has coor-
dinates v~i, j ! initialized as 0 ~1  i, j  15! except v~i, i !  1.
Then, each of the 70 triad judgments obtained from a subject was
treated as a set of dissimilarity comparisons. If the caps $k, l, m%
comprise a triad, with k and l as the similar pair and m as the
odd-one-out, then points v~k! and v~l ! are moved closer together
@v'~k, k! cos~a!v~k, k! sin~a!v~k, l !,v'~k, l ! cos~a!v~k, l !
sin~a!v~k, k!,v '~l, k!  cos~a!v~l, k!  sin~a!v~l, l !,v '~l, l ! 
cos~a!v~l, l !  sin~a!v~l, k!, a  p032  68# , while v~m! is
moved further away from them @v '~m, k!  cos~a!v~m, k! 
sin~a!v ~m, m!,v ' ~m, l !  cos~a!v ~m, l !  sin~a!v ~m, m!,
v '~m, m!  ~1 v '~m, k!2  v '~m, l !2!102# , providing new v'~k!,
v'~l !, v'~m!. After these 210 point rotations in 15-dimensional
space, D~i, j !  7v~i !  v~ j !7.
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We apply non-metric MDS ~Statistica, StatSoft, Inc.! for the
dimensional reduction of D~i, j ! to D'~i, j !, where D'~i, j ! is the
matrix of color dissimilarity in two dimensions. The outcome is a
2D MDS solution where each cap is represented by a point with
coordinates ~xi , yi ! so that the spatial distances D'~i, j ! between
the i-th and j-th points reflect D~i, j ! as closely as possible
~Kruskal & Wish, 1978!. The discrepancy between estimates and
distances was quantified by a badness-of-fit function ~Stress! and
minimized by the method of steepest descent.
Individual color spaces for each eye were computed; in addi-
tion, group color spaces for the DM2 patients and controls were
calculated as a consensus across eyes and subjects within each
group.
The axes of these 2D solutions are interpreted as the R0G and
B0Y perceptual opponent color systems. The data are too sparse to
sustain 3D individual analyses, although this would provide a
better approximation, since the stimuli varied in lightness ~Value!
and saturation ~Chroma!.
Although the relative distances D' between the coordinates
~xi , yi ! of the 15 caps are determined in the 2D color space, the
axes of the MDS output are defined arbitrarily, without any
absolute alignment ~Kruskal & Wish, 1978!. It is necessary to
rotate and mirror the coordinates to a standard orientation. We
choose that the cap 5Y should be at the top. If necessary, the
solution is mirrored horizontally to ensure that the cap 2.5R is at
the left and 10G at the right ~x10G  x2.5R!. Results are summa-
rized in Fig. 1a for control group, and ~c! and ~d! for respectively
right eye and left eye of DM2 patients’ group.
The initial use of these group color spaces is a direct compar-
ison between them. For more quantitative purposes, the 2D color
space for control group is used as a standard for assessing the
accuracy of individual color spaces in terms of the sum of resid-
uals: comparing cap locations in the individual or group solutions
against locations in the standard control group. It provides an index
of impairment to the patient’s color vision, and can be interpreted
as B0Y and R0G dimensions. The question is whether the DM2
patients’ color spaces are less accurate ~as a population! than
controls, and if so, whether their increased inaccuracy follows any
particular form.
Results and discussion
For the traditional procedure of the D-15d, TCDS was calculated
within each group of observers: controls: 60.25 6 5.84; DM2
patients: 66.04613.61, right eye, and 67.29617.32, left eye. The
difference between these results does not reach significance: right
eye: P  0.08; left eye: P  0.12 ~Mann-Whitney U Test!.
Fig. 1a shows the MDS solutions for the controls. For com-
parison, Fig. 1b shows the D-15d caps arrangement in the tradi-
tional procedure, when these are arranged errorless. The DM2
patients’ group solutions are shown in Fig. 1c for right eye and in
Fig. 1d for left eye. Features correctly reconstructed in Fig. 1a
include the arc composed by the caps, and the gap between caps
5B and 5P. In contrast, the correct sequence is not reproduced so
well by the DM2 patient solutions ~Fig. 1c and 1d!. DM2 patients’
errors are slightly greater along the B0Y axis. Across color spaces
for right eye ~R! and left eye ~L! for the DM2 group, the average
sum of residuals along the B0Y dimension were R 0.20 and L
0.32. Corresponding average residuals along the R0G dimension
were R  0.15 and L 0.21.
A quantitative comparison of individual color spaces against
the standard control group using the t-test showed that the resid-
uals are statistically significant from those of the controls: for
DM2 right eye, P  0.021, and for DM2 left eye, P  0.022
~t-test!. This comparison provides an overall index of color vision
loss.
Fig. 2a shows an example of individual solutions for a control
and Fig. 2b, Fig. 2c, and Fig. 2d show examples of solutions from
DM2 patients. Note that all these subjects performed the D-15d
test without error ~TCDS  56.41!, but the DM2 patient’s color
space is apparently more irregular. This visual impression is con-
firmed statistically: the standard color space ~Fig. 1a! accounts for
98% of fitting in Fig. 2a, and for 42.2% in Fig. 2b and 0% in
Fig. 2c and 2d.
This greater irregularity in cap locations for the DM2 patients
can be interpreted as compression of their color spaces ~so that
random noise becomes proportionally greater!. Compression can
occur along the B0Y and R0G axes independently. We quantify
axial compression—providing additional indices of color vision
impairment—by separating the summed residual distances ~based
in the comparison with the control group adopted as the standard!
interpreted as B0Y and R0G axis.
Individual color spaces obtained with the triadic procedure
were reproducible within the same subject. Repetitions of the
procedure revealed that the choice of the odd-one-out cap changed
in an average 7% from the first to the second test, which should
result in very similar compression indices. On the other hand,
when individual color spaces were considered, these indices of
compression appeared to vary dramatically among the subjects.
Even among subjects who performed the D-15d test error-free,
MDS of triadic data revealed a range of axial compression. In
the examples of Fig. 2, the summed residuals for ~Fig. 2a! control
were 0.16 ~R0G! and 0.26 ~B0Y!, as compared to DM2 patients:
~Fig. 2b! 0.22 ~R0G! and 0.30 ~B0Y!; ~Fig. 2c! 0.37 ~R0G! and
0.56 ~B0Y!; ~Fig. 2d! 0.34 ~R0G! and 0.66 ~B0Y!. This empha-
sizes a further advantage of presenting color discrimination as a
color space: it allows one to reveal very mild color vision losses in
DM2 patients without DR, and, in addition, to quantify the indi-
vidual type and degree of the impairment—unlike the traditional
use of the D-15 and D-15d tests.
The results obtained here pose a question of a possible locus
~loci! and mechanism~s! of the visual system underlying our
psychophysical findings.
It has been demonstrated ~Birch, 2001; Lutze & Bresnick,
1991! that in DM2 patients lens yellowing develops at an accel-
erated rate, similar to that in older healthy subjects. One could,
thus, argue that the B0Y compression found in the DM2 patients,
in addition to the R0G compression, is a manifestation of lens
yellowing. However, mean age of the controls in our study was
comparable to that of the DM2 patients; besides, the latter showed
no clinical signs of cataract. We therefore propose that the color
vision losses in the DM2 patients, which are revealed by compres-
sion of the B0Y ~and the R0G! axes result from reduced photo-
receptor sensitivity. Indeed, in diabetic patients elevated thresholds
of the photoreceptors were attributed to a reduction of the oxygen
supply and, hence, the concentration of circulating glucose ~Kurten-
bach et al., 2006!.
An alternative explanation for the obtained difference between
the group color spaces for the controls and DM2 patients cannot be
excluded. The set of caps used in the triadic procedure means that,
as well as varying along the chromatic R0G and B0Y axes, they
also vary in lightness and saturation, alternating between Value
50Chroma 4 and Value 80Chroma 2. This implies that a 3D
solution ~with an additional achromatic dimension! may be re-
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quired to fully account for the dissimilarity data. For controls, the
lightness variation is empirically least salient—hence it is left out
of the 2D solutions—whereas the R0G and B0Y variations are
most significant ~see Fig. 1a!. It may be that the DM2 subjects tend
to suffer a generalized loss of chromatic discrimination, which
forces them instead to place more weight on the lightness0
saturation variation when judging dissimilarity. Lightness would
therefore replace the B0Y axis as the second dimension of their
MDS solutions ~with R0G remaining as the first dimension!. In 2D
solutions, the caps would zigzag up and down between the two
values of Value0Chroma, departing from the expected angular
sequence, as in Fig. 1c and 1d. To clear up whether this is indeed
the case in DM2 patients, further study would be required using a
set with no luminance differences or using a set with a substan-
tially greater number of caps varying in Value and Chroma in order
to reconstruct the 3D color space.
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Fig. 1. ~a! , Group color space for control group; ~b! Diagram of D-15d test showing errorless cap arrangement ~TCDS  56.41!;
~c! ▫—Group color space for DM2 right eye; ~d! , Group color space for DM2 left eye. The x- and y-axes are in the same scale in
~a!, ~c!, and ~d!; they are interpreted as the B0Y and R0G perceptual opponent color systems. Error bars centered on each point i
indicate the variance in xi and yi across individual solutions.
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